Methicillin resistant Staphylococcus aureus (MRSA), particularly strains with type III staphylococcal cassette chromosome mec (SCCmec), represent a serious human pathogen in Tehran, Iran. e disease-causing capability depends on their ability to produce a wide variety of virulent factors. e prevalence of exotoxin genes and multiple-locus variable number of tandem repeats fingerprinting (MLVF) profile among MRSA isolates, from patients in Tehran, was evaluated by PCR and Multiplex-PCR. e MLVF typing of 144 MRSA isolates with type III SCCmec produced 5 di erent MLVF types. Generally, 97.2% (140/144) of all the isolates were positive for at least one of the tested exotoxin genes. e most prevalent genes were hld, found in 87.5% (126/144) of the isolates followed by lukE-lukD and hla found in 72.9% (105/144) and 70.1% (101/144) of the isolates, respectively. e tst gene, belonging to MLVF types I, IV and V, was found among three of the isolates from blood and wound samples. e sea gene was detected in 58.3% (84/144) of the isolates and the sed and see genes were found in one isolate with MLVF type V. e coexistence of genes was observed in the 87.5% (126/144) of the isolates. e rate of coexistence of hld with lukE-lukD, hla with lukE-lukD and sea with lukE-lukD were 66.7% (96/144), 44.4% (64/144) 
Introduction
Methicillin resistant Staphylococcus aureus (MRSA) is a nosocomial and community pathogen causing various infections, ranging from simple superficial skin infec tions to more life-threatening ones, including endocarditis, pneumonia, and toxic shock syndrome (Jarraud et al., 2002; Emaneini et al., 2007; Fatholahzadeh et al., 2008) . Hospital-associated MRSA is usually accompanied by specific risk factors such as recent hospitalization, surgery, dialysis and long-term care. Risk factors for community-acquired infections include intravenous drugs, prior antimicrobial usage and underlying illnesses such as pulmonary disease, diabetesand chronic skin diseases (Moreno et al., 1995; Chambers, 1997; Baba et al., 2002) . However, the capability of S. aureus strains to produce disease depends on its ability to create a wide variety of virulence factors that contribute to colonization and disease incidence in hosts (Dinges et al., 2000) . Some S. aureus strains produce a variety of exotoxins such as staphylococcal enterotoxins (SEs), toxic shock syndrome toxin 1 (TSST-1), exfoliative (epidermolytic) toxins (ETs), several haemolysins (alpha, beta, gamma and delta) and Panton-Valentine leukocidin (PVL). Staphylococcal enterotoxins are responsible for staphylococcal food poisoning, whereas TSST-1 and ETs are the causative toxins of toxic shock syndrome and staphylococcal scalded-skin syndrome, respectively (Baba et al., 2002; Kim et al., 2006) . PVL is involved in severe diseases among children and young adults with no apparent experience of reference to healthcare establishments (Holmes et al., 2005 is a new method used for characterization of S. aureus isolates which is based upon the detection of the number variation in short sequence repeats in seven individual genes (sspA, spa, clfA, clfB, sdrC, sdrD and sdrE). ere are various reports suggesting that the production of staphylococcal toxins does vary according to genotype. Moreover, it has also been suggested that the staphylococcal toxin profiles of particular isolates may be in uenced by their geographic origins (Moore et al., 2001; Baba et al., 2002; Banks et al., 2003) .
A recent study has reported a high incidence of MRSA with SCCmec type III in Tehran (Fatholahzadeh et al., 2008) . However, the properties of their virulence factors are unknown. is study was designed to determine the prevalence of di erent exotoxins and genotypes among the MRSA isolates, obtained from patients in Tehran.
Experimental

Material and Methods
MRSA Isolates.
A total of 144 clinical isolates of MRSA with SCCmec type III were involved in the present study. ese isolates were selected from a collection of 178 MRSA strains obtained from various nosocomial infection sites (wound, blood, respiratory, cerebrospinal uid, pleural uid, osteomyelitis, catheter-related infection, septicemia and urine) from patients who developed infections within the first 48 hr of their admission to a hospital in Tehran. e collection process was carried out during April 2008 to March 2009 from di erent wards of the hospital. Only one isolate was investigated per patient. To confirm the identification of the isolate as MRSA, the femA and mecA gene were amplified by a PCR-based method, using primers femA-F-5'-AAA AAG CAC ATA ACA AGC G-3' , femA-R-5'GAT AAA GAA GAA ACC AGC AG-3', mecA-F 5'-TGG CTA TCG TGT CAC AAT CG-3' and mecA-R 5'-CTG GAA CTT GTT GAG CAG AG-3' (Mehrotra et al., 2000) .
e MRSA isolates were confirmed as type III SCCmec using the method described by Oliveira et al. (Oliveira and de Lencastre, 2002) .
e WBG525 (EMRSA-1, SCCmec type III, ccr 3) strain were used as control.
Toxin gene detection. All the isolates were tested for the presence of genes encoding haemolysins (alpha, beta, gamma and delta), TST, ETA, ETB, SEA, SEB, SEC, SED, SEE, LUKE and LUKF by PCR and Multiplex -PCR using previously described primers (Mehrotra et al., 2000; Jarraud et al., 2002) . S. aureus ATCC 14458, NCTC 7428 and ATCC 49775 were used as controls.
MLVF typing. e primers used to detect clfA, clfB, sdrCDE, spa, and sspA were as described by Sabat et al. (Sabat et al., 2003) . e conditions of multiplex PCR were as described by Tenover et al. (Tenover et al., 2007) with some modifications, which are as follows; the PCR was performed in a final volume of 25 μL containing 2 units of Taq DNA polymerase, 1X of PCR bu er, 0.2 mM of each deoxynucleoside triphosphate, 2.5 mM MgCl2, 1 μmol/ml of ClfA-F/R, 0.6 μmol/ml of ClfB-F/R, CdrCDE-F/R, Spa-F/R, SspA-F/R and 6 μl of DNA template. e cycles included 94°C for 5 min for the first cycle followed by 30 cycles of 94°C for 40 s, 53°C for 40 s, 72°C for 1 min and a final cycle of 72°C for 5 min. Amplified products were analyzed by electrophoresis on 2% agarose gel. DNA bands were visualized by staining with ethidium bromide and photographed under UV illumination. MLVA profiles were analyzed visually using the criteria of Sabat et al. (Sabat et al., 2003) . Any pattern di ering by one or more bands was considered as a distinct type.
Results and Discussion
MRSA is a pathogen of serious notice in Tehran for being a cause of a wide variety of nosocomial infections. A high prevalence rate of MRSA with SCCmec type III was previously reported in this region (Fatholahzadeh et al., 2008) . In order to identify the ability of MRSA strains to produce virulence factors, a population of 144 clinical MRSA isolates, causing a broad spectrum of infections, was investigated.
e MLVF typing of the 144 isolates produced 5 di erent MLVF types (Fig. 1) . Ninety three isolates (64.6%) were identified as type I, eighteen (12.5%) as type II, fourteen (9.7%) as type III, twelve (8.3%) as type IV and seven isolates (4.9%) as type V. e observation of di erent MLVF types among a single SCCmec type has not been previously reported. However, different MLVF types with identical PFGE patterns have been shown in the MRSA isolates (Moser et al., 2009 ). In the current study, the MRSA isolates belonged to a type of MLVF pattern that is widely distributed across various wards as well as among all the age groups of patients. is fact suggests that one major MRSA clone was circulated in the hospitals under assay. is was in agreement with the previous reports of other authors who had indicated that a few MRSA clones were predominant in nosocomial infections (Teixeira et al., 1995; Stefani and Varaldo, 2003) . 305 Table I . Generally, 97.2% (140/144) of all the isolates were positive for at least one of the exotoxin genes tested. is was higher than the data reported by Kim et al. (Kim et al., 2006) , who had found that 85.5% of the MRSA isolates produced one or more toxins.
S. aureus produces a number of cytotoxins including alpha, beta, delta and gamma hemolysins and Leukocidal toxin encoded by hla, hlb, hld, hlg, and lukElukD genes respectively. ese toxins are important in several staphylococcal diseases (Dinges et al., 2000) . In the present study, the prevalence of these genes were 59%, 15.2%, 87.5%, 2.1% and 72.2%, respectively.
is contrasted the results obtained by Kocsis et al. (Kocsis et al., 2009 ) who reported a high prevalence rate of such genes among MRSA strains, isolated from Austria and Hungry. Although the genes encoding haemolysin toxins are located on chromosomes, the prevalence of these genes can be reduced by acquiring movable genes on genetic elements. e prevalence of lukS-PV-lukF-PV gene among MRSA isolates di ers noticeably in di erent countries (Jarraud et al., 2002; Karahan et al., 2008) . In this study, all the isolates were negative for the lukS-PV-lukF-PV gene. is may be due to the fact that the tested isolates only carried the SCCmec type III. Other studies have shown that the gene encoding PVL is the molecular marker for community acquired-MRSA which usually carries type IV SCCmec element (Jarraud et al., 2002; Karahan et al., 2008) .
e genes encoding SEs are carried on various genetic elements including phages (sea, see), plasmids (sed) and pathogenicity island (seb and sec) (Novick et al., 2001; Lawrynowicz-Paciorek et al., 2007) . e present study also detected enterotoxin genes among 58.3% of the isolates. is shows a 16% lower rate than the data reported by Kim et al. (Kim et al., 2006) who reported that 74.4% of the MRSA isolates with SCCmec type III were positive for enterotoxin genes and that the sea genes were the most prevalent (58.3%). However, the distribution pattern of the enterotoxin genes was di erent in the current study showing 74.4% sea and 48.8% see. In this study, the sec gene was not detected in any of the isolates and the seb gene was amplified in one isolate belonging to MLVA type IV from the wound associated with sea and tst genes. e sed and see genes associated with sea and tst, were observed in one isolate obtained from the blood belonging to the MLVA type V.
Coexistence of genes was observed in 87.5% (126/144) of the isolates. e rate of coexistence of hld with lukE-lukD, hla with lukE-lukD and sea with lukElukD were 66.7% (96/144), 44.4% (64/144) and 44.4% (64/144), respectively. e coexistence of sea with lukElukD, observed in this study, has also been reported by other studies (Schmitz et al., 1997; Gravet et al., 1999) None of the MRSA isolates, in this study, were positive for the genes encoding the exfoliative toxin. is result is in agreement with other investigations showing a low prevalence rate of this gene among the tested isolates (Becker et al., 2003; Cha et al., 2006) . As reported previously, only some strains of the S. aureus produce exfoliative toxins, whilst approximately all the isolates produce enzymes and hemolysins that contribute to their pathogenicity (Becker et al., 2003) .
e tst gene encodes TSST-1, which is associated with staphylococcal toxic shock syndrome (TSS) and is considered to be the cause of nearly all cases of menstrual TSS and at least 50% of non-menstrual cases (Cha et al., 2006) . Our results revealed that 3 isolates from blood and wound expressed the tst gene, in combination with other toxin genes. ese isolates belonged to MLVF types I, IV and V.
Finally, it is concluded that the MRSA strains with type III SCCmec indicate di erent MLVF patterns and staphylococcal toxin profiles.
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